4//SEC Filing
Saunders Michael E 4
Accession 0001097264-05-000004
CIK 0001097264other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 7:07 PM ET
Size
7.6 KB
Accession
0001097264-05-000004
Insider Transaction Report
Form 4
Saunders Michael E
VP, Clinical Development
Transactions
- Purchase
Common Stock
2004-12-31$1.85/sh+2,500$4,633→ 2,500 total
Holdings
- 50,000
Stock Options (Right to buy)
Exercise: $1.90From: 2005-07-21Exp: 2014-07-21→ Common Stock (50,000 underlying) - 52,000
Stock Options (Right to buy)
Exercise: $2.99From: 2004-12-15Exp: 2013-12-15→ Common Stock (52,000 underlying)
Footnotes (1)
- [F1]Represents shares acquired under the Company's Employee Stock Purchase Plan.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeother
Related Parties
1- filerCIK 0001308926
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 7:07 PM ET
- Size
- 7.6 KB